| The pharmacological profile of (-)deprenyl (selegiline) and its relevance for humans: a personal view. | |
| | |
MedLine Citation:
|
PMID: 1608919 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
(-)Deprenyl (selegiline, jumex, eldepryl, movergan) which is closely related to phenylethylamine (PEA) is a drug with a unique pharmacological spectrum. Single dose effects: (a) It is a highly potent and selective inhibitor of B-type monoamine oxidase (MAO). (b) In contrast to other MAO inhibitors it inhibits the noradrenaline releasing effect of tyramine, is therefore free of the 'cheese effect'. Multiple dose effects unrelated to MAO inhibition: (a) It enhances superoxide dismutase and catalase activity in the striatum. (b) It facilitates the activity of the nigrostriatal dopaminergic neurones. (c) It prevents age-related morphological changes in the neurocytes of the substantia nigra. Consequences of multiple dose effects: Compared to salt solution-treated rats, male rats maintained on (-)deprenyl loose their capacity to ejaculate later on; retain for longer their learning ability; and live longer. Freshly diagnosed Parkinson's patients maintained on (-)deprenyl, required levodopa later than their placebo-treated peers. Patients treated with levodopa plus (-)deprenyl live longer than those on levodopa alone. Chronic treatment with (-)deprenyl improves the performance of patients with Alzheimer's disease. |
| | |
Authors:
|
J Knoll |
Related Documents
:
|
1159629 - Extraneuronal monoamine oxidase in rat heart: biochemical characterization and electron... 14978359 - Interactions of human- and rat-organic anion transporters with pravastatin and cimetidine. 3021279 - Aminophylline shortens thiopental sleep-time and enhances noradrenergic neurotransmissi... 4281339 - The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium ... 20493079 - The oxidation of adrenaline and noradrenaline by the two forms of monoamine oxidase fro... 8925849 - Synthesis and in vivo studies of a specific monoamine oxidase b inhibitor: 5-[4-(benzyl... 12003759 - Confirmation of uterotrophic activity of 3-(4-methylbenzylidine)camphor in the immature... 9745139 - Cutaneous microdialysis in the rat: insertion trauma and effect of anaesthesia studied ... 8203619 - Role of endogenous vasopressin in development of gastric ulcer induced by restraint and... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Pharmacology & toxicology Volume: 70 ISSN: 0901-9928 ISO Abbreviation: Pharmacol. Toxicol. Publication Date: 1992 May |
Date Detail:
|
Created Date: 1992-07-23 Completed Date: 1992-07-23 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 8702180 Medline TA: Pharmacol Toxicol Country: DENMARK |
Other Details:
|
Languages: eng Pagination: 317-21 Citation Subset: IM |
Affiliation:
|
Department of Pharmacology, Semmelweis University of Medicine, Budapest, Hungary. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Alzheimer Disease
/
drug therapy Animals Brain / drug effects Humans Parkinson Disease / drug therapy Selegiline / administration & dosage, pharmacology* |
| Chemical | |
Reg. No./Substance:
|
14611-51-9/Selegiline |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Dental amalgam and mercury.
Next Document: Studies on the mechanism of acetonitrile toxicity. I: Whole body autoradiographic distribution and m...